* NextGen Healthcare Inc NXGN.OQ NXGN.O is expected
to show a
rise in quarterly revenue when it reports results on May 17.
* The Atlanta Georgia-based company is expected to report
a
4.1% increase in revenue to $150.065 million from $144.19
million a year ago, according to the mean estimate from 6
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for NextGen Healthcare
Inc is
for earnings of 19 cents per share. For the same quarter last
year, the company reported earnings of 21 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 3
"hold" and 1 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for NextGen
Healthcare Inc is $22.5, above its last closing price
of $19.74.
* Previous quarterly performance (using preferred earnings
measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Dec. 31 2021 0.20 0.21 0.24 Beat 15.2
Sep. 30 2021 0.24 0.23 0.29 Beat 26.1
Jun. 30 2021 0.21 0.21 0.25 Beat 20.3
Mar. 31 2021 0.19 0.19 0.21 Beat 8.8
Dec. 0.24 0.25 0.26 Beat 5.4
31 2020
Sep. 30 2020 0.20 0.20 0.30 Beat 48.5
Jun. 30 2020 0.08 0.08 0.21 Beat 152
Mar. 31 2020 0.19 0.19 0.20 Beat 3
This summary was machine generated May 14 at 02:01 GMT. All
figures in US dollars unless otherwise stated